Avricore Health Inc (AVCR) - Total Liabilities

Latest as of December 2025: CA$173.56K CAD ≈ $125.55K USD

Based on the latest financial reports, Avricore Health Inc (AVCR) has total liabilities worth CA$173.56K CAD (≈ $125.55K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Avricore Health Inc - Total Liabilities Trend (2000–2025)

This chart illustrates how Avricore Health Inc's total liabilities have evolved over time, based on quarterly financial data. See AVCR net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Avricore Health Inc Competitors by Total Liabilities

The table below lists competitors of Avricore Health Inc ranked by their total liabilities.

Company Country Total Liabilities
California Software Company Limited
NSE:CALSOFT
India Rs33.05 Million
Knosys Ltd
AU:KNO
Australia AU$7.55 Million
Yu Group PLC
LSE:YU
UK GBX177.10 Million
Caledonia Mining Corporation Plc
LSE:CMCL
UK GBX116.79 Million
ZhongDe Waste Technology AG
F:ZEF
Germany €18.24 Million
21st Century Management Services Limited
NSE:21STCENMGM
India Rs64.99 Million
Highway Holdings Limited
NASDAQ:HIHO
USA $1.87 Million
Ragusa Minerals Ltd
AU:RAS
Australia AU$123.10K

Liability Composition Analysis (2000–2025)

This chart breaks down Avricore Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Avricore Health Inc (AVCR) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.11 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.45 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Avricore Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Avricore Health Inc (2000–2025)

The table below shows the annual total liabilities of Avricore Health Inc from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 CA$173.56K
≈ $125.55K
-47.54%
2024-12-31 CA$330.82K
≈ $239.31K
-37.49%
2023-12-31 CA$529.22K
≈ $382.83K
-12.51%
2022-12-31 CA$604.89K
≈ $437.57K
+616.04%
2021-12-31 CA$84.48K
≈ $61.11K
-92.68%
2020-12-31 CA$1.15 Million
≈ $834.88K
+71.27%
2019-12-31 CA$673.85K
≈ $487.45K
+114.44%
2018-12-31 CA$314.24K
≈ $227.32K
-21.85%
2017-12-31 CA$402.09K
≈ $290.87K
+12.52%
2016-12-31 CA$357.34K
≈ $258.50K
+45.13%
2015-12-31 CA$246.23K
≈ $178.12K
+31.59%
2014-12-31 CA$187.12K
≈ $135.36K
+18.94%
2013-12-31 CA$157.32K
≈ $113.80K
-56.82%
2012-12-31 CA$364.30K
≈ $263.53K
-72.83%
2011-12-31 CA$1.34 Million
≈ $970.00K
+6.68%
2010-12-31 CA$1.26 Million
≈ $909.29K
+12.86%
2009-12-31 CA$1.11 Million
≈ $805.68K
+1881.27%
2008-12-31 CA$56.22K
≈ $40.67K
-2.95%
2007-12-31 CA$57.92K
≈ $41.90K
-22.01%
2006-12-31 CA$74.27K
≈ $53.72K
+24.81%
2005-12-31 CA$59.50K
≈ $43.04K
+99.24%
2004-12-31 CA$29.86K
≈ $21.60K
-2.22%
2003-12-31 CA$30.54K
≈ $22.09K
-70.51%
2002-12-31 CA$103.56K
≈ $74.91K
+1833.89%
2001-12-31 CA$5.36K
≈ $3.87K
+32.78%
2000-12-31 CA$4.03K
≈ $2.92K
--

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research
Market Cap
$3.66 Million
CA$5.06 Million CAD
Market Cap Rank
#29137 Global
#1367 in Canada
Share Price
CA$0.05
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.09
All Time High
CA$8.32
About

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018… Read more